These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22653170)

  • 1. Hypersensitivity reactions to vaccine constituents: a case series and review of the literature.
    Leventhal JS; Berger EM; Brauer JA; Cohen DE
    Dermatitis; 2012; 23(3):102-9. PubMed ID: 22653170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to vaccine components.
    Heidary N; Cohen DE
    Dermatitis; 2005 Sep; 16(3):115-20. PubMed ID: 16242081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?
    Offit PA; Jew RK
    Pediatrics; 2003 Dec; 112(6 Pt 1):1394-7. PubMed ID: 14654615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine hypersensitivity--update and overview.
    Fritsche PJ; Helbling A; Ballmer-Weber BK
    Swiss Med Wkly; 2010 May; 140(17-18):238-46. PubMed ID: 20349363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvants and additives in vaccines--medical relevance].
    Wiedermann-Schmidt U; Maurer W
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):510-9. PubMed ID: 16160800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed allergic skin reactions to vaccines.
    Aquino MR; Bingemann TA; Nanda A; Maples KM
    Allergy Asthma Proc; 2022 Jan; 43(1):20-29. PubMed ID: 34983706
    [No Abstract]   [Full Text] [Related]  

  • 7. Lessons in giving vaccines: soft tissue complications of vaccinations.
    Moss AL
    J Public Health (Oxf); 2005 Jun; 27(2):236-7. PubMed ID: 15820992
    [No Abstract]   [Full Text] [Related]  

  • 8. Global Advisory Committee on Vaccine Safety, June 2012.
    Wkly Epidemiol Rec; 2012 Jul; 87(30):281-7. PubMed ID: 22905369
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components.
    Echeverría-Zudaire LA; Ortigosa-del Castillo L; Alonso-Lebrero E; Álvarez-García FJ; Cortés-Álvarez N; García-Sánchez N; Martorell-Aragonés A
    Allergol Immunopathol (Madr); 2015; 43(3):304-25. PubMed ID: 25891956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report of Subcutaneous Nodules and Sterile Abscesses Due to Delayed Type Hypersensitivity to Aluminum-Containing Vaccines.
    Lauren CT; Belsito DV; Morel KD; LaRussa P
    Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27677573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodule on the upper arm.
    Lam M; Patel AN; Leach IH
    Clin Exp Dermatol; 2014 Oct; 39(7):844-6. PubMed ID: 25142411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adverse reactions to vaccines].
    Ito Tsuchiya FM; Rosas Vargas MA; Zepeda Ortega B; Río del Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2007; 54(3):86-95. PubMed ID: 17849794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS).
    Russell M; Pool V; Kelso JM; Tomazic-Jezic VJ
    Vaccine; 2004 Dec; 23(5):664-7. PubMed ID: 15542187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse reactions to vaccines].
    Eseverri JL; Ranea S; Marin A
    Allergol Immunopathol (Madr); 2003; 31(3):125-38. PubMed ID: 12783762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itching nodules and hypersensitivity to aluminium after the use of adsorbed vaccines from SSI.
    Thierry-Carstensen B; Stellfeld M
    Vaccine; 2004 May; 22(15-16):1845. PubMed ID: 15121293
    [No Abstract]   [Full Text] [Related]  

  • 17. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.
    Glanz JM; Newcomer SR; Daley MF; McClure DL; Baxter RP; Jackson ML; Naleway AL; Lugg MM; DeStefano F
    Vaccine; 2015 Nov; 33(48):6736-44. PubMed ID: 26518400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine adverse events: separating myth from reality.
    Kimmel SR
    Am Fam Physician; 2002 Dec; 66(11):2113-20. PubMed ID: 12484693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine allergy evaluation and management at the specialized Green Channel Consultation Clinic.
    Micheletti F; Peroni D; Piacentini G; Schweiger V; Mirandola R; Chiesa E; Zanoni G
    Clin Exp Allergy; 2012 Jul; 42(7):1088-96. PubMed ID: 22702507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study.
    Papadimitriou I; Bakirtzi K; Sotiriou E; Vakirlis E; Hatzibougias D; Ioannides D
    Clin Exp Dermatol; 2022 Jan; 47(1):157-158. PubMed ID: 34288056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.